Skip to main
AMN
AMN logo

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 57%
Hold 14%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services demonstrated resilience in its financial performance, reporting 2Q25 revenue of $658.2 million, which surpassed estimates and consensus despite an 11% year-over-year decline. The company achieved a gross margin of 29.8%, exceeding guidance and showcasing a sequential improvement of 120 basis points, which indicates effective cost management strategies. Additionally, AMN has consistently exceeded revenue and EBITDA estimates over the past four quarters, with average surprises of +3% for revenue and +12% for EBITDA, reflecting operational strength and market adaptability.

Bears say

AMN Healthcare Services Inc reported a significant decline in several key revenue segments, with nurse and allied solutions experiencing a 9% year-over-year decrease to $101.8 million, while the physician and leadership solutions segment fell 14% year-over-year, amounting to $381.9 million. Additionally, the overall operating margin for the nurse and allied solutions segment decreased by 30 basis points quarter-over-quarter, signaling potential inefficiencies in operations. The substantial drop in vendor management system (VMS) revenue, down 31% year-over-year, further underscores the challenges facing the company’s revenue streams and operational performance.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.